2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 3.01 USD -1.63%
Market Cap: 155.3m USD
Have any thoughts about
2Seventy Bio Inc?
Write Note

2Seventy Bio Inc
Investor Relations

2seventy Bio, Inc. operates as cell and gene therapy company. The company is headquartered in Cambridge, Massachusetts and currently employs 437 full-time employees. The company went IPO on 2021-10-18. The firm is focused on the research, development, and commercialization of transformative treatments for cancer. Its approach combines its expertise in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. The company is advancing multiple preclinical and clinical programs in oncology. The firm's lead preclinical programs in B cell non-Hodgkin's lymphoma (B-NHL) and acute myeloid leukemia are illustrations of its multiplex approach applied to address the specific challenges of treating those cancers. The company is developing bbT369 product candidate as a treatment for patients with B-NHL.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. William D. Baird III, M.B.A.
CEO, President & Director
No Bio Available
Ms. Victoria Eatwell
Chief Financial Officer
No Bio Available
Ms. Jessica Snow
Senior VP of Quality and Head of Operations
No Bio Available

Contacts

Address
MASSACHUSETTS
Cambridge
60 Binney Street
Contacts
+13394999300.0